Systematic review of ixabepilone for treating metastatic breast cancer. - Wikidata - awgldk - TriplyDB

Systematic review of ixabepilone for treating metastatic breast cancer.

Systematic review of ixabepilone for treating metastatic breast cancer.

http://www.wikidata.org/entity/Q30248627

about

The synthetic antihyperlipidemic drug potassium piperate selectively kills breast cancer cells through inhibiting G1-S-phase transition and inducing apoptosis.Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan.Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial).Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm

P2860

Q41471022-15D4244E-DE39-486A-85D2-7A6D55FC7005 Q52603297-034DF37B-26C5-4D50-9D2A-C5B091CB2C51 Q54963093-59FB1799-7C97-4480-BA2F-8CB511C2A279 Q57114388-B3C0B25C-792F-44CD-8EB7-8A54DDCE64F3

P2860

Systematic review of ixabepilone for treating metastatic breast cancer.

http://www.wikidata.org/entity/Q30248627

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Systematic review of ixabepilone for treating metastatic breast cancer.

@ast

Systematic review of ixabepilone for treating metastatic breast cancer.

@en

type

label

Systematic review of ixabepilone for treating metastatic breast cancer.

@ast

Systematic review of ixabepilone for treating metastatic breast cancer.

@en

prefLabel

Systematic review of ixabepilone for treating metastatic breast cancer.

@ast

Systematic review of ixabepilone for treating metastatic breast cancer.

@en

P1433

Q30248627-215A0784-011F-4959-98DC-278B679D124F

P1476

Q30248627-5D732850-189C-462B-867C-BA916A540723

P2093

Q30248627-1733B889-C871-4CC3-A8A2-2BBA27960C08

Q30248627-254C8485-95DB-48D1-854D-4C5C0E499637

Q30248627-262DA6C8-ADB4-4577-810F-547E0A93D596

P2860

Q30248627-12152FD9-F937-4202-90B1-88B2FF1732BD

Q30248627-365D7DCC-5265-4964-B8FC-8FEF13CA79CD

Q30248627-42A6E92A-5B7E-4EF1-9B9C-C326DD890F21

Q30248627-552025EF-7588-4782-89DE-57454CF3901F

Q30248627-5A54C47C-FFA5-4469-BBEA-21DB15D59F07

Q30248627-618D0657-52BE-49C0-B495-2C52BBC172F9

Q30248627-6312A781-B598-4643-A385-147BF4D6FB20

Q30248627-67F6D3B5-E719-41BD-834C-635FAF3CE55F

Q30248627-7149C4B8-820F-4950-948E-745211DCE31B

Q30248627-77735C5A-8678-44B9-ACB3-2A72E8977625

P2888

Q30248627-61175EF9-337C-420F-926E-3E3FFF2193D3

P304

Q30248627-4A9EE7E6-0C99-4F9D-98A3-718C2B576979

P31

Q30248627-20EB41ED-61D0-496F-A3A4-E28087467994

Q30248627-EB0D2AE1-5D39-407E-935E-60D9816ADB76

Q30248627-bdccbc9b-68f6-468a-8c6e-2cec5b818b9d

P356

Q30248627-1113F3AC-9927-4369-B025-9A3F39190194

P433

Q30248627-FE4D94E7-458B-4177-8DB9-9197A215FB25

P478

Q30248627-66A8EA9E-32DB-4C85-AC4D-DB49DA6F4460

P577

Q30248627-3E7F0C8E-5022-4561-97B4-07F6A1693D04

P6179

Q30248627-859ED795-B576-4C64-AFF0-4193CE1EA065

P698

Q30248627-EEFDCB4C-E4B9-4B2F-ADCB-D91693D8C6BE

P356

S12282-016-0717-0

P1433

P1476

Systematic review of ixabepilone for treating metastatic breast cancer.

@en

P2093

Jing Li

http://www.w3.org/2001/XMLSchema#string

Jing Ren

http://www.w3.org/2001/XMLSchema#string

Wenxia Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

Induction of morphological and biochemical apoptosis following prolonged mitotic blockage by halichondrin B macrocyclic ketone analog E7389

Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Epothilone B and its analogs - a new family of anticancer agents.

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial.

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NC

Randomised, phase II trial comparing oral capecitabine (Xeloda) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines.

P2888

s12282-016-0717-0

P304

171-179

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1007/S12282-016-0717-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012311266

http://www.w3.org/2001/XMLSchema#string

P698

27491426

http://www.w3.org/2001/XMLSchema#string